|
|
Article: Stem Cell Innovations Advancing Drug Discovery With PluriCells.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
At a time when the issue of embryonic stem cell research is making headlines again in the wake of a Senate bill calling for federal funding followed by the anticipation of an almost-certain presidential veto, a Houston-based cell biology company quietly is advancing its research with a slightly less controversial stem cell source.
Founded early last year, Stem Cell Innovations Inc. (SCI) was formed by the merger of three companies - Amphioxus Cell Technologies Inc., which focused on in vivo toxicology, along with Plurion Inc., which had intellectual property relating to stem cell lines and Interferon Sciences Inc., a public shell that ...